by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Bioactive Services USA, LLC / Herstat Inc. Warning Letter Details

Warning Letter

Bioactive Services USA, LLC / Herstat Inc.

Bioactive Services USA, LLC / Herstat Inc., 1309 Coffeen Ave, STE 1200 Sheridan , WY 82801 United States

Issue DateOctober 01, 2026

FEI NumberN/A

Violations1

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

Unapproved New Drugs

Bioactive Services USA, LLC / Herstat Inc. FDA Warning Letter, October 1, 2026